TensorTip COG Device From Cnoga, Israel To Measure The Blood Sugar Levels
Currently, a patient with diabetes is checking the blood sugar (glucose) levels for multiple times in a day with a finger-pricking (a painful procedure) device. The scientists for the last several years are trying to develop an innovative and non-invasive device that can measure the blood sugar (glucose) levels quickly, accurately and easily. They successfully developed the blood sugar measuring device such as semi-invasive needle sensor. But still, these devices need the insertion of the needle under the skin and the needle has to be changed regularly.
Cnoga Medical Ltd company, Caesarea, a North-central Israel based startup has developed the TensorTip COG glucometer device, which is the first commercially available, non-invasive, needle-free and Combo Glucometer to measure the blood sugar (glucose) levels accurately for a patient of type 2 diabetes (T2D) or pre-diabetes. A glucometer for a patient of type 1 diabetes (T1D) is under development.
The glucometer device uses the light emitting diodes (LED), a camera, a glucose meter (approved in several countries), supported algorithms and a software program. The product is equipped with an add-on blood sugar meter. The user can use the regular test strips to calibrate the device or during an emergency.
The user needs to insert the finger into the device for about 40 seconds to measure the blood glucose levels. The glucometer device uses a camera as a sensor to detect the changes in the LED light reflected from the finger to measure the blood sugar levels. The blood sugar level data will be displayed on the monitor. The data can be sent to a health care center with the help of a Cloud or a Smartphone.
The product is a non-invasive device to measure the blood sugar levels for a number of times every day. The product can be used for more than two years. The product is economical when the entire period of use was considered. But the product has to be calibrated by finger pricking for a few times a day in the first week.
The product underwent a clinical examination in Germany. The trial has validated the device technology, performance and accuracy. Trials were conducted on adult patients. The device is not yet approved for children. The results of TensorTip COG device are similar to the needle sensors.
The device was approved or certified in China, Brazil and the European Union. The Cnoga Medical Ltd Company is planning for US FDA approval in the current year. The price of the product is between $1,000 and $1,500 and it is available on the company website.
The company has plans to develop a pocket-sized, all-in-one product called the MTX device to measure and monitor the health parameters (which require invasive tests) such as.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.